Literature DB >> 14530788

H1-Antihistamines: more relevant than ever in the treatment of allergic disorders.

F Estelle R Simons1.   

Abstract

Histamine is an important chemical mediator of inflammation, vasodilation, increased vascular permeability, decreased peripheral resistance, airway smooth muscle contraction, and sensory nerve stimulation causing itching. It also plays a significant role in neurotransmission and in cardiac function. In allergic rhinoconjunctivitis and urticaria, there is strong evidence for the role of H(1)-antihistamine treatment. In asthma, additional dose-response studies, including higher doses of antihistamines than those used in allergic rhinitis, are needed to determine the role of antihistamines. In atopic dermatitis, the itch-relieving topical glucocorticoid-sparing effects of H(1)-antihistamines also require further documentation. The potential benefits of each H(1)-antihistamine should be weighed against the potential risks, and second-generation H(1)-antihistamines with excellent, well-documented safety records should be used in preference to older, less safe H(1)-antihistamines. Second-generation H(1)-antihistamines are more relevant than ever in the treatment of allergic disorders.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14530788     DOI: 10.1016/s0091-6749(03)01876-1

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  10 in total

Review 1.  [Allergen-specific Immunotherapy for children and adolescents - a review on available products in Austria].

Authors:  Zsolt Szépfalusi; Waltraud Emminger; Franz Eitelberger; Manfred Götz; Andrea Grillenberger; Elisabeth Horak; Isidor Huttegger; Dieter Koller; Helmut Litscher; Rudolf Schmitzberger; Eva-Maria Varga; Josef Riedler
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

Review 2.  Clinical practice: Allergen-specific immunotherapy in children: facts and FAQs.

Authors:  Zsolt Szépfalusi; Saskia Gruber; Thomas Eiwegger; Eleonora Dehlink
Journal:  Eur J Pediatr       Date:  2010-12-10       Impact factor: 3.183

3.  Prescription writing trends of antihistamines at the university health centre.

Authors:  Anil Kumar
Journal:  Indian J Pharm Sci       Date:  2009-05       Impact factor: 0.975

4.  Anaphylaxis to Chlorpheniramine Maleate and Literature Review.

Authors:  Yong Won Choi; Min Je Jung; Hye One Kim; Bo Young Chung; Chun Wook Park
Journal:  Ann Dermatol       Date:  2019-07-01       Impact factor: 1.444

5.  Synthesis and Anti-inflammatory Performance of Newly Cyclizine Derivatives on Adult Male Wistar Rats.

Authors:  Abbas Ahmadi; Mohsen Khalili; Shahnaz Chavrogh; Babak Nahri-Niknafs
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

Review 6.  Histamine, histamine receptors, and neuropathic pain relief.

Authors:  Ilona Obara; Vsevolod Telezhkin; Ibrahim Alrashdi; Paul L Chazot
Journal:  Br J Pharmacol       Date:  2019-06-07       Impact factor: 8.739

7.  Effects of chlorpheniramine on emergence agitation after general anesthesia for ureteroscopic stone surgery: a retrospective cohort study.

Authors:  Choon-Kyu Cho; Minhye Chang; Seok-Jin Lee; Sung-Ae Cho; Tae-Yun Sung
Journal:  Anesth Pain Med (Seoul)       Date:  2021-10-14

8.  Suppression of matrix metalloproteinase production in nasal fibroblasts by tranilast, an antiallergic agent, in vitro.

Authors:  Toshiyuki Shimizu; Kenichi Kanai; Kazuhito Asano; Tadashi Hisamitsu; Harumi Suzaki
Journal:  Mediators Inflamm       Date:  2005-08-14       Impact factor: 4.711

9.  Hyeonggaeyeongyo-Tang for Treatment of Allergic and Nonallergic Rhinitis: A Prospective, Nonrandomized, Pre-Post Study.

Authors:  Min-Hee Kim; Jaewoong Son; Hae Jeong Nam; Seong-Gyu Ko; Inhwa Choi
Journal:  Evid Based Complement Alternat Med       Date:  2016-09-06       Impact factor: 2.629

10.  Efficacy and safety of So-Cheong-Ryong-Tang in treatment of perennial allergic rhinitis: study protocol for a double-blind, randomised, parallel-group, multicentre trial.

Authors:  Min-Hee Kim; Youme Ko; Jin-Hyang Ahn; Younghee Yun; Mi-Na Yun; Seong-Gyu Ko; Inhwa Choi
Journal:  BMJ Open       Date:  2017-09-27       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.